Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Julián Rodríguez-Suárez"'
Autor:
Julián Rodríguez Suárez, Corsino Rey Galán, Isolina Riaño Galán, Juan José Díaz Martín, Laura Muñoz Fernández, César Bazó Canelón
Publikováno v:
Educación Médica, Vol 25, Iss 1, Pp 100878- (2024)
Resumen: En este artículo haremos un breve recorrido por el uso, la terminología y los recursos disponibles en el campo de la salud digital (centrado en la telemedicina y las videoconsultas) y cómo podemos abordar la incorporación de la competenc
Externí odkaz:
https://doaj.org/article/2c9f663050a441a29c284f8041935eab
Autor:
Javier Arístegui, Santiago Alfayate-Miguelez, Begoña Carazo-Gallego, Elisa Garrote, Laura Díaz-Munilla, Mikel Mendizabal, María Méndez-Hernández, Elia Doménech, Belén Ferrer-Lorente, María Unsaín-Mancisidor, José Tomás Ramos-Amador, Marta Illán-Ramos, Borja Croche-Santander, Fernando Centeno Malfaz, Julián Rodríguez-Suárez, Manuel Cotarelo Suárez, María San-Martín, Jesús Ruiz-Contreras
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Rotavirus (RV) is the most common cause of severe gastroenteritis (GE) in infants and young children worldwide and is associated with a significant clinical and economic burden. The objective of this study was to analyze the characteristics, healthca
Externí odkaz:
https://doaj.org/article/d24272bc6762455dac1e378b33fe333f
Autor:
Óscar Álvarez-García, Enrique García-López, Vanessa Loredo, Helena Gil-Peña, Natalia Mejía-Gaviria, Julián Rodríguez-Suárez, Flor Á Ordóñez, Fernando Santos
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34788 (2012)
Rapamycin, an immunosuppressant agent used in renal transplantation with antitumoral properties, has been reported to impair longitudinal growth in young individuals. As growth hormone (GH) can be used to treat growth retardation in transplanted chil
Externí odkaz:
https://doaj.org/article/928014f8317840e4bf91ca68d34365b3
Autor:
Flor A. Ordoñez, Fernando Santos, Olaya Hernández-Frías, Enrique García-López, Rocío Fuente, Helena Gil-Peña, Débora Claramunt, Vanessa Loredo, Julián Rodríguez-Suárez
Publikováno v:
American Journal of Physiology-Renal Physiology. 309:F57-F62
Growth retardation is a major manifestation of chronic kidney disease (CKD) in pediatric patients. The involvement of the various pathogenic factors is difficult to evaluate in clinical studies. Here, we present an experimental model of adenine-induc
Autor:
Eduardo Carbajo-Pérez, Helena Gil-Peña, Fernando Santos, Enrique García-López, Julián Rodríguez-Suárez, Flor A. Ordoñez, Vanessa Loredo, Oscar Alvarez-Garcia
Publikováno v:
American Journal of Physiology-Renal Physiology. 297:F639-F645
Hypokalemic tubular disorders may lead to growth retardation which is resistant to growth hormone (GH) treatment. The mechanism of these alterations is unknown. Weaning female rats were grouped ( n = 10) in control, potassium-depleted (KD), KD treate
Autor:
Juan José Lozano, Pablo Secades-Vázquez, Oscar Alvarez-Garcia, Eduardo Carbajo-Pérez, Enrique García-López, Fernando Santos, Helena Gil, Julián Rodríguez-Suárez
Publikováno v:
Growth Hormone & IGF Research. 18:353-359
Objectives Treatment with growth hormone (GH) improves growth retardation of chronic renal failure. cDNA microarrays were used to investigate GH-induced modifications in gene expression in the tibial growth plate of young rats. Design RNA was extract
Autor:
Rocío Fuente, Flor A. Ordoñez, Fernando Santos, Enrique García-López, Julián Rodríguez-Suárez, Olaya Hernández Frías, Helena Gil-Peña, Débora Claramunt
Publikováno v:
Pediatric Research. 82:888-888
BackgroundIn a model of growth retardation secondary to chronic kidney disease (CKD) induced by adenine, this study explores the effects of growth hormone (GH) therapy on growth plate and mineral metabolism.MethodsWeaning female rats receiving a 0.5%
Autor:
Enrique García-López, Julián Rodríguez-Suárez, Vanessa Loredo, Flor A. Ordoñez, Helena Gil-Peña, Natalia Mejía-Gaviria, Oscar Alvarez-Garcia, Fernando Santos
Publikováno v:
SCOPUS
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
PLoS ONE
PLoS ONE, Vol 7, Iss 4, p e34788 (2012)
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
PLoS ONE
PLoS ONE, Vol 7, Iss 4, p e34788 (2012)
Rapamycin, an immunosuppressant agent used in renal transplantation with antitumoral properties, has been reported to impair longitudinal growth in young individuals. As growth hormone (GH) can be used to treat growth retardation in transplanted chil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be0f58a3e40b803d4e7ee5c58e7ce59
http://hdl.handle.net/10651/9544
http://hdl.handle.net/10651/9544
Autor:
Flor A. Ordoñez, Eduardo Carbajo-Pérez, Julián Rodríguez-Suárez, Oscar Alvarez-Garcia, Fernando Santos, Enrique García-López, Helena Gil-Peña, Vanessa Loredo
Publikováno v:
Kidney international. 78(6)
Rapamycin, a potent immunosuppressant used in renal transplantation, has been reported to impair longitudinal growth in experimental studies. Rapamycin is both antiproliferative and antiangiogenic; therefore, it has the potential to disrupt vascular
Publikováno v:
Journal of Clinical Pediatric Nephrology. 2:64
Background: The correct management of febrile urinary tract infections (UTI) is important to prevent acute complications and long-term kidney damage. Diagnosis of UTI is difficult in infants, what often leads to aggressive procedures to collect urine